Article
Functional mRNA delivery to hematopoietic stem and progenitor cells <i>in vivo</i>
2022-12-18
Abstract excerpt
Gene correction of hematopoietic stem cells (HSC) is a promising therapeutic approach for multiple disorders. Current methods, however, require HSC collection from patients, gene correction during ex vivo culture, and re-infusion of corrected HSC into patients conditioned with chemotherapeutic agents. These approaches are complex, and the conditioning creates toxicities. We show that a lipid nanoparticle (LNP) ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fa7d2ea-1190-5f95-b301-205ea4e0fc09
- DOI
- 10.1101/2022.12.15.520650
